Tech Company Financing Transactions

Step Pharma Funding Round

Step Pharma, based in Saint-Genis-Pouilly, secured $3 million in funding from European Innovation Council Fund.

Transaction Overview

Company Name
Announced On
2/19/2026
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Undisclosed
Proceeds Purpose
The company intends to use the funds to accelerate the clinical development of its lead candidate, dencatistat, specifically for CTPS2 null ovarian and endometrial cancers, including expanding Phase 1b trials and preparing for Phase 2 studies.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
15 rue Louis et Auguste Lumière, Technoparc du Pays-de-Gex
Saint-Genis-Pouilly, 01630
France
Phone
Undisclosed
Email Address
Not Recorded
Overview
Step Pharma is the world leader in CTPS1 inhibition. Step Pharma is pioneering a novel class of oral drugs that specifically inhibit the enzyme cytidine triphosphate synthase 1 (CTPS1). Step Pharma is led by a highly motivated management team and an exceptional syndicate of international investors, all driven to bring about a step change in cancer treatment for patients.
Profile
Step Pharma LinkedIn Company Profile
Social Media
Step Pharma Company Twitter Account
Company News
Step Pharma News
Facebook
Step Pharma on Facebook
YouTube
Step Pharma on YouTube

Management Team

Title
Name
Email & Social
Chairman
Erik Van Den Berg
  Erik Van Den Berg LinkedIn Profile  Erik Van Den Berg Twitter Account  Erik Van Den Berg News  Erik Van Den Berg on Facebook
Chief Executive Officer
Andrew Parker
  Andrew Parker LinkedIn Profile  Andrew Parker Twitter Account  Andrew Parker News  Andrew Parker on Facebook
Chief Financial Officer
Nicolas Marsault
  Nicolas Marsault LinkedIn Profile  Nicolas Marsault Twitter Account  Nicolas Marsault News  Nicolas Marsault on Facebook
Chief Medical Officer
Karen Smith
  Karen Smith LinkedIn Profile  Karen Smith Twitter Account  Karen Smith News  Karen Smith on Facebook
Chief Scientific Officer
Philip Beer
  Philip Beer LinkedIn Profile  Philip Beer Twitter Account  Philip Beer News  Philip Beer on Facebook
Vice President
Maureen Higgins
  Maureen Higgins LinkedIn Profile  Maureen Higgins Twitter Account  Maureen Higgins News  Maureen Higgins on Facebook
VP - Bus. Development
Duc Tran
  Duc Tran LinkedIn Profile  Duc Tran Twitter Account  Duc Tran News  Duc Tran on Facebook


 

 

Browse more venture capital transactions:

Prev: 2/19/2026: Orion Properties venture capital transaction
Next: 2/19/2026: Code Metal venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We do our best to document funding rounds that are announced publicly. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary